Background {#Sec1}
==========

Elevated resting heart rate has been demonstrated to be associated with type 2 diabetes \[[@CR1]\], metabolic syndrome \[[@CR2], [@CR3]\], cardiovascular disease, and all-cause mortality \[[@CR4], [@CR5]\]. As a global index of the influence of the autonomic nervous system on the heart, an elevated RHR can be considered as a reflex in response to autonomic imbalance, which refers to excessive sympathetic activity and too little parasympathetic activity \[[@CR6]\]. Insulin resistance plays pivotal roles in the early development of hyperlipidemia, hyperglycemia, central adiposity, and atherosclerosis \[[@CR7]\]. Furthermore, it is well documented that hyperinsulinism itself can trigger sympathetic nervous system activity \[[@CR8], [@CR9]\].

Although studies have clearly demonstrated the value of RHR in predicting the risk of mortality as well as the incidence of metabolic diseases, the influence of RHR on glucose metabolism has not been fully elucidated. Previous studies have confirmed that RHR is significantly associated with type 2 diabetes independently of conventional confounders \[[@CR1], [@CR10]\]. Most recently, Lawson et al. investigated the correlation of autonomic imbalance as measured by RHR with heart rate variability and metabolic risk outcomes and found that RHR and HRV, along with sex, age, and smoking were significant predictors of hyperglycemia and a diagnosis of diabetes within 12 years of follow-up \[[@CR11]\].

However, to date, a very limited number of studies have reported conflicting data on the relationship between heart rate and glucose metabolism regulation \[[@CR12]--[@CR16]\]. In the present study, we sought to evaluate the association between the resting heart rate and states of glucose metabolism in a cross-sectional study of Chinese individuals aged 40--70 years.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

The present study is a part of the risk evaluation of cancers in Chinese diabetic individuals, i.e., the longitudinal (REACTION) study that was a population-based cross-sectional study among middle-aged and elderly Chinese individuals aged 40--70 years in 25 communities across mainland China, conducted from 2011 to 2012. The details of the study design have been described previously \[[@CR17], [@CR18]\]. Briefly, all studied individuals came from the Chongming District in Shanghai, China. A total of 9930 eligible subjects were recruited. After excluding those who did not have resting heart rate measurements (*n* = 32), 9898 subjects (3194 men and 6704 women) were found to be eligible for the present analysis. The study protocol was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine. Written informed consent was obtained from all of the participants.

Data collection {#Sec4}
---------------

The baseline data were collected by trained health workers via a standardized questionnaire during interviews. The measurements of weight, height, waist circumference, and blood pressure have been described previously. Smoking (current, former, or never) and alcohol drinking (current, former, or never) were assessed using an interview preceding the physical examination. The physical activity levels were classified as low, moderate, or high according to the International Physical Activity Questionnaire scoring protocol. BMI was calculated as weight in kilograms divided by the square of height in meters. RHR was measured and calculated from ECG recordings after subjects had ≥ 30 min rest and had been in the supine position ≥ 5 min.

All subjects were assessed after overnight fasting for at least 10 h. Overnight fasting and 2-h OGTT blood samples were collected. The fasting glucose, glucose 2 h after oral glucose tolerance test, triglycerides, total cholesterol (TC), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol were measured with an automatic analyzer (Hitachi 7080; Tokyo, Japan). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated according to the equation described by Matthews et al. \[[@CR19]\]. The abbreviated Modification of Diet in Renal Disease formula recalibrated for the Chinese was used to estimate the glomerular filtration rates, which are expressed in milliliters per minute per 1.73 m^2^ as follows: estimated glomerular filtration rate (eGFR) = 186 × \[serum creatinine × 0.011\]^-1.154^ × \[age\]^-0.203^ × \[0.742 if female\] × 1.233, where serum creatinine is expressed as micromoles per liter and 1.233 is the adjustment coefficient for the Chinese \[[@CR20]\].

Impaired glucose regulation and type 2 diabetes {#Sec5}
-----------------------------------------------

Impaired glucose regulation was defined as IFG (i.e., a fasting plasma glucose level ≥ 6.1 and \< 7.0 mmol/l) and/or IGT (2-h OGTT plasma glucose level ≥ 7.8 and \< 11.1 mmol/l). Isolated IFG was defined as a fasting plasma glucose ≥ 6.1 mmol/l and \< 7.0 mmol/l and a 2-h OGTT plasma glucose \< 7.8 mmol/l. Isolated IGT was defined as a 2-h OGTT plasma glucose ≥ 7.8 mmol/l and \< 11.1 mmol/l and a fasting glucose \< 6.1 mmol/l. IFG/IGT was defined by a fasting plasma glucose between 6.1 mmol/l and 6.9 mmol/l and a 2-h OGTT plasma glucose of 7.8 mmol/l to 11.0 mmol/l. Type 2 diabetes was diagnosed according to the 1999 World Health Organization criteria (fasting plasma glucose level ≥ 7.0 mmol/l and/or a 2-h OGTT plasma glucose level ≥ 11.1 mmol/l or the current use of antidiabetic medication). A fasting glucose level lower than 6.1 mmol/l and a 2-h OGTT plasma glucose level below 7.8 mmol/l were defined as normal glucose regulation (NGR).

Statistical analysis {#Sec6}
--------------------

The statistical analyses were performed with the SPSS Statistical Package (version 13.0; SPSS Inc., Chicago, IL). The participants' characteristics are presented according to the RHR quartiles, which were defined as follows: \< 71, 71--78, 79--86 and \> 86 bpm. Analyses of covariance (general linear regression model) were applied for continuous variables, and multivariate logistic regression analyses were applied for the categorical variables for the comparisons according to the RHR quartiles. A multivariable stepwise regression analysis was used to investigate the association of RHR with cardiovascular and metabolic related parameters. A multivariate logistic regression model was used to evaluate the ORs and 95% CIs of having IGR or IGR + T2DM for each quartile of RHR compared with the lowest quartile with adjustments for potential confounding covariates. Finally, a multiple linear regression analysis was performed to determine the associations of fasting glucose, 2-h OGTT plasma glucose and A1c with the other related variables. When appropriate, natural log-transformed values were used for the analyses. *P* values \< 0.05 were considered statistically significant.

Results {#Sec7}
=======

The general clinical characteristics of the study population are presented in Table [1](#Tab1){ref-type="table"}. Across the resting heart rate quartiles, the subjects with the higher resting heart rates were more likely to be of lower age, have smaller waist circumferences, have high lipid profiles and have chronic systemic inflammation. These subjects also tended to have an adverse glucose metabolism profile. Additionally, these subjects were less likely to be male, smokers and alcohol drinkers than those in the lower resting heart rate quartiles.Table 1Participants' characteristics according to resting heart rate quartilesVariableRHR quartile (bpm)*P* valueQ1 \< 71Q2 71--78Q3 79--86Q4 \> 86n2166269125632478Mean RHR, bpm65 ± 475 ± 282 ± 296 ± 8\< 0.001Males, n (%)962 (44.4)859 (31.9)701 (27.4)672 (27.1)\< 0.001Age (years)57.6 ± 7.556.1 ± 7.655.6 ± 8.055.2 ± 8.3\< 0.001WC (cm)85.3 ± 11.984.9 ± 10.284.7 ± 9.983.7 ± 10.4\< 0.001Waist/hip ratio0.9 ± 0.10.9 ± 0.10.9 ± 0.20.9 ± 0.10.002BMI (kg/m^2^)24.7 ± 3.324.7 ± 3.424.8 ± 7.824.3 ± 3.50.001SBP (mm Hg)129 ± 20130 ± 18132 ± 20132 ± 19\< 0.001DBP (mm Hg)78 ± 1079 ± 1081 ± 1083 ± 10\< 0.001FPG (mmol/L)6.1 ± 1.46.1 ± 1.66.5 ± 1.516.6 ± 2.2\< 0.0012hPPG (mmol/L)8.0 ± 3.58.3 ± 3.78.7 ± 3.79.7 ± 4.5\< 0.001HbA1c5.9 ± 0.96.0 ± 1.06.0 ± 1.06.1 ± 1.2\< 0.001Fasting insulin (μU/ml)6.0 (4.2--8.4)6.5 (4.7--8.9)6.8 (4.9--9.5)7.0 (5.0--9.7)\< 0.001HOMA-IR1.6 (1.2--2.4)1.7 (1.3--2.6)1.8 (1.3--2.7)2.0 (1.4--2.9)\< 0.001TC (mmol/L)4.6 ± 1.04.6 ± 1.04.6 ± 1.14.8 ± 1.1\< 0.001TG (mmol/L)1.3(0.9--1.9)1.3 (0.9--1.9)1.4 (1.0--2.1)1.5 (1.0--2.2)\< 0.001LDL-c (mmol/L)2.6 ± 0.72.6 ± 0.82.6 ± 0.82.7 ± 0.80.022HDL-c (mmol/L)1.22 ± 0.311.22 ± 0.311.21 ± 0.311.25 ± 0.33\< 0.001eGFR (ml min^−1^ 1.73 m^−2^)124.5 ± 25.6125.8425.4126.5 ± 25.8124.1 ± 25.30.001CRP (mg/L)1.3 (0.5--3.4)1.4 (0.5--3.4)1.5 (0.6--3.7)1.6(0.7--3.8)\< 0.001Current smokers, n (%)379 (17.5)351 (13.0)290 (11.3)270 (10.9)\< 0.001Current drinkers, n (%)247 (11.4)286 (10.6)242 (9.4)226 (9.1)0.033IGR, n (%)666 (30.8)887 (33.0)927 (36.2)935 (37.7)\< 0.001Type 2 diabetes, n (%)484 (22.4)578 (21.5)646 (25.2)817 (33.0)\< 0.001The values are presented as the means ± the SDs, the medians (interquartile ranges) or the numbers (proportions)*RHR* resting heart rate, *bpm* beats/min, *WC*, waist circumference, *BMI* body mass index, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *FPG* fasting plasma glucose, *2hPPG* 2-h post-load plasma glucose, *HbA1c* hemoglobin A1c, *TC* total cholesterol, *TG* triglycerides, *LDL* low-density lipoprotein-cholesterol, *HDL* high-density lipoprotein-cholesterol, *eGFR* estimated glomerular filtration rate, *CRP* C reactive protein, *IGR* impaired glucose regulation

Table [2](#Tab2){ref-type="table"} presents the results of regression analyses of resting heart rate with other cardiovascular and metabolic related parameters. In both the simple and multiple adjusted linear regression analyses, resting heart rate was positively associated with fasting plasma glucose, 2-h OGTT plasma glucose, A1c, HOMA-IR, systolic blood pressure, diastolic blood pressure, and triacylglycerol and negatively associated with BMI and waist circumference.Table 2Adjusted regression coefficients for resting heart rate according to cardiovascular- and metabolism-related parametersModel 1Model 2Model 3ß (SEM)*P* valueß (SEM)*P* valueß (SEM)*P* valueFPG0.170 (0.143)\< 0.0010.164 (0.144)\< 0.0010.167 (0.145)\< 0.0012hPPG0.196 (0.051)\< 0.0010.198 (0.051)\< 0.0010.197 (0.051)\< 0.001HbA1c0.190 (0.218)\< 0.0010.187 (0.220)\< 0.0010.188 (0.220)\< 0.001Fasting insulin0.049 (0.019)\< 0.0010.046 (0.021)\< 0.0010.041 (0.021)\< 0.001HOMA-IR0.023 (0.049)0.0310.026 (0.050)0.0170.027 (0.050)0.014SBP0.140 (0.009)\< 0.0010.140 (0.009)\< 0.0010.141 (0.009)\< 0.001DBP0.276 (0.016)\< 0.0010.277 (0.016)\< 0.0010.277 (0.016)\< 0.001BMI− 0.037 (0.027)0.003− 0.025 (0.029)0.035− 0.025 (0.029)0.039WC− 0.086 (0.014)\< 0.001− 0.054 (0.027)0.014− 0.057 (0.027)0.010TG0.042 (0.094)\< 0.0010.046 (0.099)\< 0.0010.049 (0.100)\< 0.001HDL-c0.014 (0.414)0.2130.013 (0.415)0.227)0.017 (0.423)0.116Model 1: adjusted for age and sex; Model 2: further adjusted for smoking, drinking, and physical activity; Model 3: further adjusted for CRP and eGFR

Resting heart rate levels were significantly higher in the subjects with isolated IFG, isolated IGT, combined IFG and IGT, and type 2 diabetes compared with the subjects with normal glucose regulation (79.3, 80.2, 82.2, and 83.1 bpm, respectively, vs. 77.5 bpm, all *p* \< 0.01) after adjusting for age and sex. The risk of having impaired glucose regulation increased progressively across the lowest to the highest quartiles of resting heart rate with ORs of 1.44 (95% CI 1.24--1.68), 1.93 (95% CI 1.66--2.25), and 2.19 (95% CI 1.85--2.58), respectively (P~*trend*~ \< 0.001) after adjusting for sex, age, smoking, alcohol drinking, physical activity, BMI, waist circumference, SBP, DBP, and lipid profiles. For eGFR and CRP, the OR of have both impaired glucose regulation and type 2 diabetes was 2.56 (95% CI 2.20--2.98) after controlling for all the covariates in model 4 (Table [3](#Tab3){ref-type="table"}).Table 3ORs for the risk of impaired glucose regulation and type 2 diabetes by resting heart rate quartileResting heart rate quartiles (bpm)P for trendQ1 \< 72Q2 72--79Q3 80--86Q4 \> 86IGR Model 111.43 (1.25--1.64)1.96 (1.72--2.24)2.41 (2.09--2.78)\< 0.001 Model 211.48 (1.28--1.72)2.03 (1.76--2.35)2.38 (2.04--2.78)\< 0.001 Model 311.47 (1.26--1.71)2.01 (1.73--2.34)2.30 (1.95--2.71)\< 0.001 Model 411.44 (1.24--1.68)1.93 (1.66--2.25)2.19 (1.85--2.58)\< 0.001IGR + T2DM Model 111.60 (1.41--1.80)2.28 (2.02--2.57)2.80 (2.46--3.18)\< 0.001 Model 211.64 (1.43--1.87)2.35 (2.06--2.67)2.79 (2.42--3.20)\< 0.001 Model 311.64 (1.43--1.89)2.33 (2.03--2.68)2.75 (2.37--3.19)\< 0.001 Model 411.60 (1.39--1.84)2.20 (1.91--2.53)2.56 (2.20--2.98)\< 0.001Model 1: adjusted for sex and age; Model 2: further adjusted for smoking, alcohol drinking, and physical activity; Model 3: further adjusted for BMI, waist circumference, SBP, DBP, and lipid profiles; Model 4: further adjusted for eGFR and CRP

To further understand the influence of resting heart rate on the prevalence of impaired glucose regulation and type 2 diabetes, multiple regression analyses were performed. The analyses revealed that resting heart rate remained significantly associated with fasting plasma glucose, 2-h post-load plasma glucose and A1c (Table [4](#Tab4){ref-type="table"}) after adjusting for all potentially confounding covariates.Table 4Multiple linear regression analysis assessing the associations of fasting plasma glucose, 2-h OGTT plasma glucose and A1c with RHR in men and womenDependent variableVariableBSEStandardized B*p* valueMen FPGAge0.0260.0030.112\< 0.001HOMA-IR0.1910.0070.291\< 0.001RHR0.0220.0020.136\< 0.001(R^2^ = 0.169; F-value = 115.6), p \< 0.0012-h PPGAge0.0690.0040.141\< 0.001HOMA-IR0.3560.0180.238\< 0.001RHR0.0490.0030.175\< 0.001(R^2^ = 0.572; F-value = 113.8), p \< 0.001HbA1cAge0.0220.0020.0161\< 0.001HOMA-IR0.0990.0040.259\< 0.001RHR0.0070.0020.071\< 0.001(R^2^ = 0.121; F-value = 73.8), p \< 0.001WomenFPGAge0.0300.0020.109\< 0.001HOMA-IR0.1770.0070.285\< 0.001RHR0.0170.0030.144\< 0.001(R^2^ = 0.160; F-value = 118.6), p \< 0.0012-h PPGAge0.0690.0050.148\< 0.001HOMA-IR0.3610.0170.237\< 0.001RHR0.0550.0040.182\< 0.001(R^2^ = 0.612; F-value = 114.8), p \< 0.001HbA1cAge0.0250.0020.0173\< 0.001HOMA-IR0.1020.0050.263\< 0.001RHR0.0070.0030.081\< 0.001(R^2^ = 0.152; F-value = 77.9), p \< 0.001*FPG* fasting plasma glucose, *2hPPG* 2-h post-load plasma glucose, *RHR* resting heart rate

Discussion {#Sec8}
==========

The novel finding of the present study is the independent association of a higher resting heart rate with impaired glucose regulation. Additionally, an elevated resting heart rate was also significantly associated with increased insulin resistance.

An elevated resting heart rate level has been found to be an independent predictor of cardiovascular and all-cause mortality \[[@CR4], [@CR21], [@CR22]\]. Additionally, recent studies have indicated that a relatively high HR has direct detrimental effects on the progression of coronary atherosclerosis \[[@CR23]--[@CR26]\]. Clinical trial data have confirmed that HR reduction itself has a good effect on subjects with cardiovascular disease \[[@CR4]\]. Furthermore, most recent studies have provided evidence that RHR is an independent risk factor of type 2 diabetes and metabolic syndrome \[[@CR1], [@CR3]\]. Whereas the above studies support the role of RHR in predicting the risks of mortality and the prevalence of metabolic diseases, in this study, we demonstrated that higher resting heart rate was a good indicator of an increased risk of impaired glucose regulation in middle-aged and elderly Chinese individuals, independent of potential confounders.

In line with previous studies \[[@CR27]--[@CR29]\], we also found that there was a significant association between RHR and fasting plasma insulin levels. Furthermore, multivariable stepwise regression analysis revealed that a higher RHR was an independent risk factor for insulin resistance. The results are consistent those of previous studies \[[@CR27], [@CR30]\] that have stated that elevated RHR levels are markedly correlated with increased insulin resistance. Resting heart rate is largely determined by the activity of the autonomic nervous system and hemodynamic states and has been recognized as an integrated index of the heart that is influenced by the autonomic nervous system. In a sense, the RHR is related to sympathetic activity or autonomic imbalance. Previous studies have suggested that there are links between sympathetic nervous activity, hyperinsulinemia and insulin resistance \[[@CR31]--[@CR33]\].

Impaired glucose regulation, also referred to as prediabetes, is associated with a relatively high risk for the future development of diabetes \[[@CR34]\]. IGR is a highly heterogeneous metabolic state, both with respect to its pathogenesis and the prediction of disease \[[@CR35]\]. IGR should not be viewed as a clinical entity in its own right but rather as a risk factor for diabetes and cardiovascular disease. Furthermore, it has been well documented that IGR is associated with hypertension, dyslipidemia with high triglycerides and/or low HDL cholesterol, and visceral obesity. Additionally, substantial epidemiological evidence indicates that the onsets of cardiovascular disease and type 2 diabetes can be delayed or prevented via lifestyle modifications. Therefore, it is critical to clarify the mechanisms underlying impaired glucose regulation and to seek effective management measures for all modifiable risk factors. In the present study, after controlling for potential cofounders, RHR emerged as an independent risk factor for IGR. Additionally, we also demonstrated that resting heart rate was significantly associated glucose metabolism indices (including fasting plasma glucose, 2-h post-load plasma glucose and A1c) in a multivariate analysis. Moreover, emerging data have established that HR reduction therapy has a beneficial influence on patients with cardiovascular disease. In view of these facts, it is plausible to consider whether RHR alone should become a novel target of clinical intervention for abnormal glucose metabolism just as it is for cardiovascular disease.

This cross-sectional study evaluated the relationship between RHR and impaired glucose regulation in a large sample of the Chinese population. Most potential confounders were carefully controlled, which limited the possibility of residual confounding effects. Furthermore, in our study, RHR data were collected via echocardiography, which enabled a precise RHR measurement. Our study does have several limitations. Given the cross-sectional nature of the study design, a cause-effect relationship between RHR and impaired glucose regulation could not be inferred. Further prospective study is needed to dissect the potential pathophysiological mechanism of this correlation. Additionally, the data were obtained from middle-aged and older people, and the gender proportions were unbalanced, which may limit the extrapolation of the results to a more general population. Moreover, this study used a single heart rate measurement, which was derived from ECG and might not represent the true resting heart rate. It would be more appropriate to have multiple resting heart rate measurements and to use the heart rate trend or at least an average heart rate measurement for the analysis.

Conclusions {#Sec9}
===========

In summary, our findings suggested that elevated resting heart rate is strongly and independently associated with an increased risk of having impaired glucose regulation. As a familiar and accessible clinical variable, resting heart rate is a simple measurement that can be used to monitor abnormal glucose regulation in the population. Our results may have important public health implications. However, longitudinal studies are warranted to determine the clinical significance of these findings.

Not applicable.

Funding {#FPar1}
=======

This work was supported by the Shanghai Science and Technology Commission (15,411,953,200, 16,140,901,200, 14ZR1427400), National Natural Science Foundation of China (81,300,667, 81,370,953, 81,370,935), Shanghai Health System Outstanding Young Talents Training Program (XYQ2013098), Shanghai Education Committee Key Program (14zz110), Shanghai Pujiang Program (16PJ1401700), National Clinical Research Center for Metabolic Diseases (2013BAI09B13) and National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006--001).

Availability of data and materials {#FPar2}
==================================

The data that support the findings of this study are available from REACTION Study Group but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of REACTION Study Group.

Conceived and designed the experiments: LQ, QS. Performed the experiments: ZY, WZ, NL, YN, LZ, XL. Analyzed the data: ZY. Contributed reagents/materials/analysis tools: ZY, WZ, NL, YN, LZ, XL, SL, HZ, XW, JW, GN. Wrote the paper: ZY, WZ. All authors read and approved the final manuscript.

Ethics approval and consent to participate {#FPar3}
==========================================

The study protocol was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine. Written informed consent was obtained from all the participants. The methods were carried out in accordance with the approved guidelines.

Consent for publication {#FPar4}
=======================

Not applicable.

Competing interests {#FPar5}
===================

The authors declare that they have no competing interests.

Publisher's Note {#FPar6}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
